Gene therapy for infectious diseases: the AIDS model

Eli Gilboa, Clay Smith

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Abstract

Genetic manipulation of somatic cells may be of therapeutic value in a variety of infectious diseases, particularly in human immunodeficiency virus (HIV) infection. Stable insertion of custom-designed 'resistance genes' into cells susceptible to HIV could reduce the viral burden in infected individuals and potentially retard the characteristic progressive immune dysfunction. Alternatively, ectopic expression of genes that encode viral antigens might induce potent antiviral immune responses and form the basis for novel prophylactic and therapeutic vaccines. While laboratory studies have proved that the approach works in principle, preclinical and clinical studies will be necessary to evaluate the therapeutic benefit of such gene-based therapies.

Original languageEnglish (US)
Pages (from-to)139-144
Number of pages6
JournalTrends in Genetics
Volume10
Issue number4
DOIs
StatePublished - Apr 1994
Externally publishedYes

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Gene therapy for infectious diseases: the AIDS model'. Together they form a unique fingerprint.

Cite this